Process for preparing recombined placental growth factor
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GEYMONAT
- Publication Date
- 2005-05-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to a method for extracting and purifying recombinant placental growth factor from genetically modified cells. Background technique
[0002] Placental growth factor (PLGF) is a homodimeric glycoprotein with a similar structure to vascular endothelial growth factor (VEGF). The complete polynucleotide sequence encoding the PLGF protein is described by Maglione and Persico in Italian patent EP-B-550 519 (WO-A-92 / 06194) of September 27, 1990 claiming priority. Different processes of splicing the ARN of PLGF generate three homologous forms of placental growth factor, specifically PLGF-1, PLGF-2 and PLGF-3, with distinct polypeptide sequences, all described in the literature.
[0003] The above-mentioned patents also describe methods for the production of PLGF factors, including the use of an inducible prokaryotic expression system characterized by a host cell modified by an expression vector in which the human PLGF gene is i...